Supplementary Figure 2 from Resistance to Selective FGFR Inhibitors in <i>FGFR-</i>Driven Urothelial Cancer

<p>Documentation of the allelic status in cis of FGFR3 S249C and V553L mutations from MR406 tissue biopsy.</p>

Zapisane w:

Opis bibliograficzny
1. autor:	Francesco Facchinetti (16827090) (author)
Kolejni autorzy:	Antoine Hollebecque (15010338) (author), Floriane Braye (16827093) (author), Damien Vasseur (16827096) (author), Yoann Pradat (15352227) (author), Rastislav Bahleda (16617234) (author), Cédric Pobel (16617263) (author), Ludovic Bigot (16617254) (author), Olivier Déas (16827099) (author), Juan David Florez Arango (16827102) (author), Giorgia Guaitoli (16827105) (author), Hayato Mizuta (16827108) (author), David Combarel (16827111) (author), Lambros Tselikas (15019536) (author), Stefan Michiels (9081965) (author), Sergey I. Nikolaev (15061686) (author), Jean-Yves Scoazec (15036392) (author), Santiago Ponce-Aix (16827114) (author), Benjamin Besse (15061674) (author), Ken A. Olaussen (16827117) (author), Yohann Loriot (15123021) (author), Luc Friboulet (15025943) (author)
Wydane:	2025
Hasła przedmiotowe:	Cancer Therapeutic Research and Development Drug Resistance Clinical drug resistance Reversal of drug resistance Drug Targets Protein kinase & phosphatase drug targets Genitourinary Cancers Bladder cancer
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy